On October 10, Gelunhui reported that on October 9, 2024, Zhejiang Provincial Food and Drug Administration issued the "Zhejiang Provincial Food and Drug Administration No. 0188 GMP Compliance Inspection Results". Beijing Beilu Pharmaceutical Co., Ltd.'s holding subsidiary Zhejiang Haichang Pharmaceutical Co., Ltd. (hereinafter referred to as "Haichang Pharmaceutical") active pharmaceutical ingredient (Iohexol) synthesis workshops three and four, drying and packaging workshop, production line 2 passed the GMP compliance inspection.
北陆药业(300016.SZ)：海昌药业碘克沙醇原料药通过药品GMP现场符合性检查
Beijing Beilu Pharmaceutical (300016.SZ): Haichang Pharmaceutical's iodine cefalothin active pharmaceutical ingredient passed the pharmaceutical GMP on-site compliance inspection.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated